发布求助
文献互助 智能选刊 最新文献

Cardiovascular Prevention and Pharmacotherapy最新文献

筛选
英文 中文
Logistic Regression and Least Absolute Shrinkage and Selection Operator 逻辑回归、最小绝对收缩和选择算子
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2020.2.e15
Hyunyong Lee, Hun‐Sung Kim
{"title":"Logistic Regression and Least Absolute Shrinkage and Selection Operator","authors":"Hyunyong Lee, Hun‐Sung Kim","doi":"10.36011/cpp.2020.2.e15","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e15","url":null,"abstract":"Logistic regression, a model that forms a binary dependent variable and one or more independent variable(s), is used especially in epidemiological studies. By understanding the logistic model and its applications, such as odds ratio (OR) and performance efficiency, the concept of logistic regression can be easily grasped. The purpose of this article is to 1) introduce logistic regression, including odds and OR, 2) present predictive efficiency, such as area under the curve, and 3) explain the caution of logistic regression analysis.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127998318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It 糖化血红蛋白值预测模型的建立及其影响因素分析
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2021.3.e14
HyeongKyu Park, D. Lee, So young Park, Jiyoung Min, Jiwon Shinn, Dae Ho Lee, S. Kwon, Hun‐Sung Kim, N. Kim
{"title":"Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It","authors":"HyeongKyu Park, D. Lee, So young Park, Jiyoung Min, Jiwon Shinn, Dae Ho Lee, S. Kwon, Hun‐Sung Kim, N. Kim","doi":"10.36011/cpp.2021.3.e14","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e14","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129963575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modeling of Changes in Creatine Kinase after HMG-CoA Reductase Inhibitor Prescription HMG-CoA还原酶抑制剂处方后肌酸激酶变化的建模
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2021.3.e15
Hun‐Sung Kim, Jiyoung Min, Jiwon Shinn, O. Hong, J. Son, Seong-Su Lee, Sung-Rae Kim, S. Yoo
{"title":"Modeling of Changes in Creatine Kinase after HMG-CoA Reductase Inhibitor Prescription","authors":"Hun‐Sung Kim, Jiyoung Min, Jiwon Shinn, O. Hong, J. Son, Seong-Su Lee, Sung-Rae Kim, S. Yoo","doi":"10.36011/cpp.2021.3.e15","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e15","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115350757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tafamidis for Cardiac Transthyretin Amyloidosis 他法非地治疗心脏甲状腺转蛋白淀粉样变性
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/CPP.2021.3.E1
Darae Kim, Jin-Oh Choi, E. Jeon
{"title":"Tafamidis for Cardiac Transthyretin Amyloidosis","authors":"Darae Kim, Jin-Oh Choi, E. Jeon","doi":"10.36011/CPP.2021.3.E1","DOIUrl":"https://doi.org/10.36011/CPP.2021.3.E1","url":null,"abstract":"Transthyretin amyloid (ATTR) cardiomyopathy is a progressive disease caused by the infiltration of ATTR fibrils in the myocardium. Although it is a rare disease, ATTR cardiomyopathy is an important cause of heart failure with preserved ejection fraction, and its incidence is increasing due to improved diagnostic imaging tools. There has been a breakthrough in the field of transthyretin amyloidosis, which opens a new therapeutic door for the patients. In this review, an overview of tafamidis therapy in ATTR cardiomyopathy with recent results from clinical trials will be discussed.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114252025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack 抗血小板治疗对缺血性脑卒中或短暂性脑缺血发作患者继发性脑卒中的预防作用
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2021.3.e10
Kyung-Yul Lee
{"title":"Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack","authors":"Kyung-Yul Lee","doi":"10.36011/cpp.2021.3.e10","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e10","url":null,"abstract":"The risk of stroke recurrence is highest in the acute phase after transient ischemic attack (TIA) or ischemic stroke. Therefore, patients with TIA or ischemic stroke should be treated with antiplatelet medication for stroke prevention. The short-term use of dual antiplatelet therapy between 21 and 90 days may be considered in those with acute minor stroke or TIA and high-risk of recurrence. However, the long-term use of dual antiplatelet therapy is not recommended due to the risk of bleeding. The current stroke guideline does not specify the administration of an antiplatelet for the secondary prevention of ischemic stroke. However, as clinical studies progress, antiplatelet therapy may become a personalized treatment in the future.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124938785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Body Weight Change and Cardiovascular Disease: Effect of Weight Gain, Weight Loss, and Weight Cycling 体重变化与心血管疾病:体重增加、体重减轻和体重循环的影响
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2021.3.e12
J. Cho, E. Rhee, Won-Young Lee
{"title":"Body Weight Change and Cardiovascular Disease: Effect of Weight Gain, Weight Loss, and Weight Cycling","authors":"J. Cho, E. Rhee, Won-Young Lee","doi":"10.36011/cpp.2021.3.e12","DOIUrl":"https://doi.org/10.36011/cpp.2021.3.e12","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114641732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erratum: Aspirin Has a Neutral Effect in Preventing Future Cardiovascular Events in Vasospastic Angina 勘误:阿司匹林在预防血管痉挛性心绞痛患者未来心血管事件方面具有中性作用
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2020.2.e1
K. Lee, D. Shin, S. Her, S. Han, Youngkeun Ahn, Dong-Soo Kim, D. Choi, H. Kwon, H. Gwon, S. Rha, S. Jo, S. Lim, J. Myong, S. Baek
{"title":"Erratum: Aspirin Has a Neutral Effect in Preventing Future Cardiovascular Events in Vasospastic Angina","authors":"K. Lee, D. Shin, S. Her, S. Han, Youngkeun Ahn, Dong-Soo Kim, D. Choi, H. Kwon, H. Gwon, S. Rha, S. Jo, S. Lim, J. Myong, S. Baek","doi":"10.36011/cpp.2020.2.e1","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e1","url":null,"abstract":"","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129925292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's Perspective 2型糖尿病合并心血管疾病患者的治疗模式转变:心脏病专家的观点
Cardiovascular Prevention and Pharmacotherapy Pub Date : 1900-01-01 DOI: 10.36011/cpp.2020.2.e4
D. Jeon
{"title":"Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's Perspective","authors":"D. Jeon","doi":"10.36011/cpp.2020.2.e4","DOIUrl":"https://doi.org/10.36011/cpp.2020.2.e4","url":null,"abstract":"Type 2 diabetes mellitus (T2DM) is a complex disorder and is associated with an increased risk for developing atherosclerotic cardiovascular disease. Control of major risk factors of T2DM can reduce major adverse cardiovascular events (MACEs) in patients. Glycemic control has long been the gold standard for treatment of T2DM. However, strict blood glucose control strategies have repeatedly failed in the prevention of cardiovascular events in key clinical trials. The 2019 American and European practice guidelines for the prevention of cardiovascular disease in patients with T2DM have recommended the use of novel hypoglycemic agents, such as sodium glucose transporter 2 inhibitors and glucagonlike peptide-1 receptor antagonist, which have shown significant reductions in the risk of MACE in spite of their modest glycemic control capacity. A paradigm shift from the glucosecentered approach in treating diabetic patients with cardiovascular disease is imperative. Based on positive outcomes from previous evidence, the reduction of the risk of MACE should be a primary objective for treatment.","PeriodicalId":348697,"journal":{"name":"Cardiovascular Prevention and Pharmacotherapy","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127535485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信